Skip to main content
. 2014 Jan 15;46(1):27–32. doi: 10.4143/crt.2014.46.1.27

Fig. 1.

Fig. 1

Overall survival. Patients undergoing chemotherapy had a significantly longer overall survival than best supportive care (BSC) patients (median, 61 days vs. 9 days; p<0.001).